Found: 6
Select item for more details and to access through your institution.
The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma.
- Published in:
- Molecular Diagnosis & Therapy, 2018, v. 22, n. 5, p. 621, doi. 10.1007/s40291-018-0355-7
- By:
- Publication type:
- Article
Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
- Published in:
- Respiratory Research, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12931-015-0230-6
- By:
- Publication type:
- Article
Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 3, p. 425, doi. 10.3390/diagnostics11030425
- By:
- Publication type:
- Article
Immunoexpression analysis of selected JAK/STAT pathway molecules in patients with non–small-cell lung cancer.
- Published in:
- Polish Archives of Internal Medicine, 2017, v. 127, n. 11, p. 758, doi. 10.20452/pamw.4115
- By:
- Publication type:
- Article
Evaluation of the relationship between the IL-17A gene expression level and regulatory miRNA-9 in relation to tumor progression in patients with non-small cell lung cancer: a pilot study.
- Published in:
- Molecular Biology Reports, 2020, v. 47, n. 1, p. 583, doi. 10.1007/s11033-019-05164-0
- By:
- Publication type:
- Article
Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03312-w
- By:
- Publication type:
- Article